Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
0.6785
+0.0675 (11.05%)
At close: Nov 19, 2026, 4:00 PM EST
0.6715
-0.0070 (-1.03%)
After-hours: Nov 19, 2026, 7:39 PM EST
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $122.19 million as of November 19, 2026. It is the 23,639th most valuable company in the world and the 3,890th biggest in the United States. Its market cap has decreased by 86.07% in one year.
Market Cap
122.19M
Enterprise Value
-31.63M
1-Year Change
-86.07%
Global Rank
Country Rank
#3,890 United States
Category
ChartMarket Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $122.19M, a decrease of -71.93%. That is a compound annual growth rate of -20.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 122.19M | -87.21% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| enGene Therapeutics | 115.27M |
| Canton Strategic Holdings | 115.17M |
| Upstream Bio | 115.10M |
| LENZ Therapeutics | 109.97M |
| Foghorn Therapeutics | 109.73M |
| Unicycive Therapeutics | 107.98M |
| Minerva Neurosciences | 107.64M |
| Molecular Partners AG | 107.43M |